Saturn V Capital Management LLC Ironwood Pharmaceuticals Inc Transaction History
Saturn V Capital Management LLC
- $255 Billion
- Q4 2024
A detailed history of Saturn V Capital Management LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Saturn V Capital Management LLC holds 814,533 shares of IRWD stock, worth $1.21 Million. This represents 1.41% of its overall portfolio holdings.
Number of Shares
814,533
Previous 1,120,409
27.3%
Holding current value
$1.21 Million
Previous $4.62 Billion
21.83%
% of portfolio
1.41%
Previous 1.65%
Shares
4 transactions
Others Institutions Holding IRWD
# of Institutions
245Shares Held
163MCall Options Held
11.5MPut Options Held
12.9K-
Black Rock Inc. New York, NY22.9MShares$34.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.5MShares$29.1 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$24.4 Million22.5% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.7MShares$17.5 Million0.13% of portfolio
-
Armistice Capital, LLC New York, NY9.47MShares$14.1 Million0.59% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $228M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...